Literature DB >> 2987542

DNA sequence of the leftward junction in the adenovirus-simian virus 40 hybrid Ad2+D2 and determination of the structure of the D2-T antigen.

E A Baumann, C P Baur, M Baack, S Beck.   

Abstract

The nucleotide sequence of the junction between the simian virus 40 early region and the adenovirus type 2 late region L4 in the hybrid virus Ad2+D2 was determined. The deduced amino acid sequence suggests that the D2-T antigen is a chimeric protein sharing 594 amino acids with the C-terminal end of the simian virus 40 T antigen and 104 amino acids with the N terminus of the adenovirus type 2 33,000-molecular-weight protein. The predicted structure of the D2-T antigen was confirmed by an immunoprecipitation analysis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2987542      PMCID: PMC254881     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

1.  Enzymatic activities associated with a purified simian virus 40 T antigen-related protein.

Authors:  R Tjian; A Robbins
Journal:  Proc Natl Acad Sci U S A       Date:  1979-02       Impact factor: 11.205

2.  Biological activity of purified simian virus 40 T antigen proteins.

Authors:  R Tjian; G Fey; A Graessmann
Journal:  Proc Natl Acad Sci U S A       Date:  1978-03       Impact factor: 11.205

3.  The binding site on SV40 DNA for a T antigen-related protein.

Authors:  R Tjian
Journal:  Cell       Date:  1978-01       Impact factor: 41.582

Review 4.  Defective and nondefective Ad2-SV40 hybrids.

Authors:  A M Lewis
Journal:  Prog Med Virol       Date:  1977

5.  The structure and expression of two defective adenovirus 2/simian virus 40 hybrids.

Authors:  J A Hassell; E Lukanidin; G Fey; J Sambrook
Journal:  J Mol Biol       Date:  1978-04-05       Impact factor: 5.469

6.  Amount of viral DNA in the genome of cells transformed by adenovirus type 2.

Authors:  U Pettersson; J Sambrook
Journal:  J Mol Biol       Date:  1973-01       Impact factor: 5.469

7.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

8.  In vitro mutagenesis of a putative DNA binding domain of SV40 large-T.

Authors:  D Kalderon; A E Smith
Journal:  Virology       Date:  1984-11       Impact factor: 3.616

9.  A novel method to map transcripts: evidence for homology between an adenovirus mRNA and discrete multiple regions of the viral genome.

Authors:  A R Dunn; J A Hassell
Journal:  Cell       Date:  1977-09       Impact factor: 41.582

10.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

View more
  5 in total

1.  Database of mutations that alter the large tumor antigen in simian virus 40.

Authors:  T D Kierstead; J M Pipas
Journal:  Nucleic Acids Res       Date:  1996-01-01       Impact factor: 16.971

2.  Linker insertion mutants of simian virus 40 large T antigen that show trans-dominant interference with wild-type large T antigen map to multiple sites within the T-antigen gene.

Authors:  J Y Zhu; C N Cole
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

3.  An N-terminal deletion mutant of simian virus 40 (SV40) large T antigen oligomerizes incorrectly on SV40 DNA but retains the ability to bind to DNA polymerase alpha and replicate SV40 DNA in vitro.

Authors:  K Weisshart; M K Bradley; B M Weiner; C Schneider; I Moarefi; E Fanning; A K Arthur
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

4.  Effects of in vitro dephosphorylation on DNA-binding and DNA helicase activities of simian virus 40 large tumor antigen.

Authors:  K Klausing; K H Scheidtmann; E A Baumann; R Knippers
Journal:  J Virol       Date:  1988-04       Impact factor: 5.103

5.  SV40 T antigen binds directly to the large subunit of purified DNA polymerase alpha.

Authors:  I Dornreiter; A Höss; A K Arthur; E Fanning
Journal:  EMBO J       Date:  1990-10       Impact factor: 11.598

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.